Main > ONCOLOGY (**) > Solid Tumors. *** > CN. B. MSI-H or dMMR>Anti PD-1 MAb

---

CN. B. MSI-H or dMMR>Anti PD-1 MAb's subsections
(*) CN Conditional OK: 2022. 03.11
Company
dMMR: MisMatch Repair deficient
Generic Name: Tislelizumab
MSI-H: MicroSatellite Instability-H
Patent>Assignee; Claims; No.; Etc.
PR Web-Site

CN. B. MSI-H or dMMR>Anti PD-1 MAb's products
This section has no products